CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling Pathway
DOI: https://doi.org/10.2147/ijgm.s458228
IF: 2.145
2024-05-06
International Journal of General Medicine
Abstract:Yang Yang, 1– 5, &ast Mengmeng Zhang, 1, 3, 5, &ast Fenglin Cai, 6 Gang Ma, 1, 3, 5 Ru-Peng Zhang, 1, 3, 5 Yiqing Yin, 2, 4, 5 Jingyu Deng 1, 3, 5 1 Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China; 2 Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China; 3 Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, People's Republic of China; 4 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, People's Republic of China; 5 Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China; 6 Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yiqing Yin, Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, West Huan-Hu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, People's Republic of China, Email Jingyu Deng, Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China, Email Purpose: The functions of C-type lectin domain family 4 member D (CLEC4D), one member of the C-type lectin/C-type lectin-like domain superfamily, in immunity have been well described, but its roles in cancer biology remain largely unknown. Patients and Methods: This study aims to explore the role of CLEC4D in gastric cancer (GC). Bioinformatics preliminarily analyzed the expression of CLEC4D in gastric cancer. Immunohistochemical staining was used to detect the expression level and clinical pathological characteristics of CLEC4D in gastric cancer. The biological function of CLEC4D in gastric cancer cell lines was verified through in vitro and in vivo experiments. Results: In this study, CLEC4D expression was found to be markedly increased in gastric cancer (GC) tissues compared with matched normal gastric tissues, and high CLEC4D expression independently predicted unfavorable overall survival in patients with GC. Knockdown of CLEC4D markedly inhibited GC cell proliferation and migration. Mechanistically, CLEC4D knockdown deactivated the Akt and NF-κB signaling pathways in GC cells. Conclusion: Together, these results demonstrate that aberrantly increased CLEC4D expression promotes cancer phenotypes via the Akt and NF-κB signaling pathways in GC cells. Keywords: CLEC4D, gastric cancer, NF-κB signaling pathways, migration The numbers of gastric cancer (GC) cases and related deaths have declined gradually over the past 5 decades, GC remains a global health burden, as it is the fifth most frequently diagnosed malignancy and the fourth leading cause of cancer-related deaths around the world. 1 Complex host genetic and environmental factors interact with each other to contribute to the initiation and progression of GC, and most GC cases are diagnosed at advanced stages, at which point there are few effective treatment options to significantly improve patient outcomes. 2 Thus, a deeper understanding of the molecular mechanisms underlying disease progression is paramount to identifying novel biomarkers and understanding whether they can be targeted in GC treatment. The immune surveillance of cells is guided by a large number of highly conserved pattern recognition receptors (PRRs). 3 These PRRs can recognize a wide range of ligands (carbohydrates, lipids, proteins, and glycoproteins). 4 PRRs play an important role in the occurrence and development of cancer. They participate in regulating immune response, inflammatory response, and anti-tumor response by recognizing abnormal signals and changes inside and outside the cell, which is of great significance for the immune surveillance and treatment of cancer. 5 C-type lectin receptors (CLRs) are family of PRRs widely expressed in mammals, mainly involved in antigen recognition and signal transduction during the immune response. 6 The defining characteristic of CLRs is the presence of one or more C-type lectin domains (CTLDs) and the requirement for Ca 2+ ions to achieve efficient binding to carbohydrate ligands. 7 CLRs are structurally diverse, including single-chain and multic -Abstract Truncated-
medicine, general & internal